Medicine - Publications - Faculty & Research - Harvard Business School

Filter Results: (296)

Filter Results: (296)

Show Results For

← Page 8 of 296 Results →

Sort by

Are you looking for?

→Search All HBS Web

Article

Beyond Magic Bullets: True Innovation in Health Care

By: Vaibhav A. Narayan, Marco Mohwinckel, Gary Pisano, Michael Yang and Husseini Manji

The molecular medicine revolution—based on advances in fields such as genomics and network modeling in the decade since the human genome sequence was completed—has changed the way we think about, study, and approach the development of novel therapies. However, these... View Details

Keywords: Integration; Business Model; Organizational Structure; Health Care and Treatment; Innovation and Invention; Pharmaceutical Industry

Find at Harvard

June 2023
Supplement

Roche: ESG and Access to Healthcare

By: George Serafeim

In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first ESG investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that... View Details

2017
Article

The Impact of Training Informal Healthcare Providers in India: A Randomized Controlled Trial

By: Jishnu Das, Abhijit Chowdhury, Reshmaan Hussam and Abhijit Banerjee

Health care providers without formal medical qualifications provide more than 70% of all primary care in rural India. Training these informal providers may be one way to improve the quality of care where few alternatives exist. We report on a randomized controlled... View Details

Keywords: Health Care; India; Business Training; RCT; Health Care and Treatment; Training; Performance Evaluation; Performance Improvement; India

Find at Harvard

April 13, 2021
Article

Misinformation about Science in the Public Sphere

By: Dietram A. Scheufele, Andrew J. Hoffman, Liz Neely and Czerne M. Reid

This is an introduction to a special issue on a colloquium of the National Academies of Sciences, Engineering, and Medicine titled, “Advancing the science and practice of science communication: Misinformation about science in the public sphere.” This event was the... View Details

Keywords: Knowledge Dissemination; Communication Strategy; Science; Information

22 Apr 2009
Working Paper Summaries

Where is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location

Keywords: by Arthur Daemmrich; Pharmaceutical

March 2019
Article

A Time-Driven Activity-Based Costing Analysis of Emergency Department Scribes

By: Robert S. Kaplan, Heather A. Heaton, David M. Nestler, William J. Barry, Richard A. Helmers, Mustafa Y. Sir, Deepi G. Goyal, Derek A. Haas and Annie T. Sadosty

Objectives: To apply time-driven activity-based costing (TDABC) methodology to determine emergency medicine physician documentation costs with and without scribes.

Methods: Two research assistants shadowed attending physicians for a total of 64 hours in the... View Details

Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Analysis

26 Jun 2007
First Look

First Look: June 26, 2007

Working PapersTaxes, Institutions and Foreign Diversification Opportunities Authors:Mihir A. Desai and Dhammika Dharmapala Abstract Investors can access foreign diversification opportunities through either foreign portfolio investment (FPI) or foreign direct... View Details

Keywords: Martha Lagace

March 2011 (Revised February 2012)
Case

Innovation and Growth at Actelion Ltd.

By: Gary P. Pisano, Daniela Beyersdorfer and Ruth Dittrich

In late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven... View Details

Keywords: Business Model; Talent and Talent Management; Innovation and Management; Leadership; Growth and Development Strategy; Product Development; Organizational Culture; Research and Development; Biotechnology Industry; Pharmaceutical Industry; Switzerland

October 2017 (Revised August 2020)
Case

RB

By: Joshua Margolis, Vincent Dessain and Jerome Lenhardt

As 2016 was approaching its end, Rakesh Kapoor, CEO of RB, one of the world’s major fast moving consumer goods (FMCG) companies, envisioned the prospect of a major acquisition that would add a line of health-related products that promised growth in the developing... View Details

Keywords: Organization Behavior; Corporate Culture; Mergers ＆ Acquisitions; Growth; Geographic Development; Mergers and Acquisitions; Organizational Change and Adaptation; Organizational Culture; Growth and Development Strategy; France

June 2008
Article

Current State of Fellowship Hiring: Is a Universal Match Necessary? Is It Possible?

By: Christopher D. Harner, Anil S. Ranawat, Muriel Niederle, Alvin E. Roth, Peter J. Stern, Shepard R. Hurwitz, William Levine, G. Paul DeRosa and Serena S. Hu

Currently, approximately ninety percent of the six hundred twenty graduating orthopaedic residents are planning on entering a post-graduate fellowship. Since January of 2005, two of the largest fellowship match programs, Sports Medicine and Spine Surgery, were... View Details

Keywords: Medical Specialties; Recruitment; Selection and Staffing; Employment; Market Timing; Marketplace Matching; Health Industry

Find at Harvard

14 Aug 2007
Working Paper Summaries

Improving Patient Outcomes: The Effects of Staff Participation and Collaboration in Healthcare Delivery

Keywords: by Ingrid M. Nembhard, Anita L. Tucker, Jeffrey D. Horbar & Joseph H. Carpenter; Health

May 11, 2020
Article

Steer Your Family Businesses Through an Unplanned Transition

By: Josh Baron and Nick Di Loreto

In a perfect world, family businesses will transition leadership from one generation to the next along a predictable and well-planned process — whether that’s determined within the business, the ownership group, or the family itself — passing the baton after years of... View Details

Keywords: Transition; Planning; Family Business; Management Succession

Register to Read

2019
Article

Pay-for-Monopoly?: An Assessment of Reverse Payment Deals by Pharmaceutical Companies

By: Sana Rafiq and Max Bazerman

Abstract Over the past eighteen years, pharmaceutical firms have developed a blueprint to impede competition in order to maintain their monopoly profits. This scheme, termed pay-for-delay, involves direct or indirect payment of money from a branded-drug manufacturer... View Details

Keywords: Monopoly; Policy; Competition; Agreements and Arrangements; Pharmaceutical Industry

March 2009 (Revised September 2010)
Case

Dartmouth-Hitchcock Medical Center: Spine Care

By: Robert S. Huckman, Michael E. Porter, Rachel Gordon and Natalie Kindred

Describes the Spine Center at Dartmouth-Hitchcock Medical Center, a multidisciplinary unit that offers patients suffering from spinal problems "one-stop" access to a range of providers including orthopedic surgeons, neurosurgeons, neurologists, medical specialists in... View Details

Keywords: Health Care and Treatment; Medical Specialties; Service Delivery; Service Operations; Integration; Value Creation; Health Industry; United States

10 Oct 2007
First Look

First Look: First Look: October 10

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=507082 PublicationsRealizing the Promise of Personalized Medicine Authors:Mara G. Aspinall and Richard G. Hamermesh Periodical:Harvard Business Review 85, no. 10 (October... View Details

Keywords: Martha Lagace

01 Sep 2009
First Look

First Look: September 1

industries and poor selection of investments within industries. Venture capital organizations with more experience tend to outperform those with less experience. Practicing Medicine in the Age of Facebook Author:Sachin H. Jain... View Details

Keywords: Martha Lagace

Article

Decisions about Medication Use and Cancer Screening across Age Groups in the United States

By: Kathleen M. Fairfield, Bethany S. Gerstein, Carrie A. Levin, Vickie Stringfellow, Heidi Wierman and Mary McNaughton-Collins

Objective
To describe decision process and quality for common cancer screening and medication decisions by age group.

Methods
We included 2941 respondents to a national Internet survey who made at least one decision about colorectal, breast,... View Details

Keywords: Screening; Decision Making; Health Care and Treatment; Health Testing and Trials

Find at Harvard

2024
Chapter

The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives

By: Ariel Dora Stern

For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details

2022
Working Paper

The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives

By: Ariel Dora Stern

For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details

Keywords: AI and Machine Learning; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Technological Innovation; Medical Devices and Supplies Industry

Find at Harvard

May 2016
Article

Transformation of Health Care—Perspectives of Opinion Leaders

By: Joanne Disch, Thomas W. Feeley, Diana J. Mason, Richard L. Schilsky, Ellen L. Stovall and Shelley Fuld Nasso

"What Health System Transformations Do You Believe Are Necessary for the Future of Health Care?" We need to transform to a true value-based health care delivery system. That means organizing care around medical conditions, not simply around hospitals and doctors. We... View Details

Keywords: Perspective; Health Disorders; Performance Improvement; Health Care and Treatment; Transformation; Health Industry

←
8
9
…
14
15
→